Macalisang, Roel E.
HRN: 21-29-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
CEFTRIAXONE 1G (VIAL)
05/17/2022
05/24/2022
IV
1g
Q12h
Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes